Future trends for the health care industry were discussed in an Investing in Health care webinar this morning, ahead of the Jefferies Global Healthcare Conference in London this week.
Martin Brunninger, Jefferies’ managing director and senior analyst, spoke about the high growth trends in the industry which began in 1995. This was very high at the beginning of the last decade, but has trended down to single digits, despite there not being a huge change in innovation pace. He said that with higher demand for product volumes, an aging population – especially the ‘baby boomer’ generation, it is surprising that there has been a sales decline. He added that new developments such as Obamacare can lead to greater partnerships in the industry, while innovative business models on the health care services side could increase sales.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze